Company Search:
Advanced Search
Sponsored Links
IntegraGen SA Company Snapshot
IntegraGen SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares IntegraGen SA with three other companies in this sector in France: Genfit (2016 sales of 6.78 million Euro [US$8.39 million] of which 100% was Therapeutic Drugs), Carbios Sasu (8.87 million Euro [US$10.98 million] ), and GeNeuro SA (5.92 million Euro [US$7.32 million] ).

Sales Analysis. IntegraGen SA reported sales of 6.02 million Euro (US$7.45 million) for the year ending December of 2016. This represents an increase of 7.9% versus 2015, when the company's sales were 5.58 million Euro. Despite this increase, sales are still slightly below the level achieved in 2014, when IntegraGen SA reported sales of 6.04 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
IntegraGen SA
  Stock Performance Chart for IntegraGen SA
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 2.21
(Figures in Euro)
1 Week 0.5%   13 Weeks -3.9%  
4 Weeks -15.0%   52 Weeks -23.8%  
IntegraGen SA Key Data:
  Ticker: ALINT Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 6,022,393
(Year Ending Jan 2017).
Employees: 27
  Currency: Euro Market Cap: 11,097,115
  Fiscal Yr Ends: December Shares Outstanding: 5,021,319
  Share Type: Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.